Australia -
English -
Department of Health (Therapeutic Goods Administration)
abilify aripiprazole 2mg tablet blister pack
otsuka australia pharmaceutical pty ltd - aripiprazole, quantity: 2 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; magnesium stearate; maize starch; microcrystalline cellulose; hyprolose; colour - - abilify is indicated for the treatment of schizophrenia including maintenance of clinical improvement during continuation therapy. - acute treatment of manic or mixed episodes associated with bipolar i disorder in adults as monotherapy and in combination with lithium or valproate; - maintenance treatment of manic or mixed episodes in bipolar i disorder in adults as monotherapy.
Malaysia -
English -
NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)
busulfex injection
smart medicine sdn. bhd. - busulfan -
Singapore -
English -
HSA (Health Sciences Authority)
samsca tablet 15mg
otsuka pharmaceuticals (singapore) pte. ltd. - tolvaptan - tablet - tolvaptan 15mg
Singapore -
English -
HSA (Health Sciences Authority)
abilify oral solution 1mgml
otsuka pharmaceuticals (singapore) pte. ltd. - aripiprazole - solution - aripiprazole 1.0 mg/ml
Singapore -
English -
HSA (Health Sciences Authority)
abilify tablet 2mg
otsuka pharmaceuticals (singapore) pte. ltd. - aripiprazole - tablet - aripiprazole 2mg
Canada -
English -
Health Canada
busulfan for injection solution
auro pharma inc - busulfan - solution - 60mg - busulfan 60mg - antineoplastic agents
Canada -
English -
Health Canada
busulfan for injection solution
eugia pharma inc. - busulfan - solution - 60mg - busulfan 60mg
Egypt -
English -
EDA (Egyptian Drug Authority)
dextran 40 (10 %w/v) intr.infusion & glucose 5 % b.p.
otsuka egypt - infusion - 10 %
Egypt -
English -
EDA (Egyptian Drug Authority)
dextran 70 6% normal saline
otsuka egypt - infusion - 6 %
Egypt -
English -
EDA (Egyptian Drug Authority)
dextran (70) 6% w/v in normal saline i.v.infusion b.p2003
otsuka egypt - infusion - 6 %